Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_assertion type Assertion NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_head.
- NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_assertion description "[The findings of the current study suggest that adenocarcinoma cases with CIMP have a poorer prognosis than adenocarcinoma cases without CIMP, and the EGFR mutation was shown to have an inverse correlation with methylation of SPARC and the p16INK4A gene in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_provenance.
- NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_assertion evidence source_evidence_literature NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_provenance.
- NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_assertion SIO_000772 16598760 NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_provenance.
- NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_assertion wasDerivedFrom befree-20140225 NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_provenance.
- NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_assertion wasGeneratedBy ECO_0000203 NP226622.RAt6bEFNN0tNZNLmO6FMegdgibP159L_8mBgBS7fBv4zo130_provenance.